Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6211983 | 1.00 | PTGDR2 (0.32) | PTGDR2 | |
| SCHEMBL6215658 | 1.00 | PTGDR2 (0.32) | PTGDR2 | |
| SCHEMBL6218453 | 1.00 | PTGDR2 (0.32) | PTGDR2 | |
| SCHEMBL6212294 | 1.00 | PTGDR2 (0.32) | PTGDR2 | |
| SCHEMBL6212255 | 1.00 | PTGDR2 (0.32) | PTGDR2 | |
| SCHEMBL5971336 | 0.86 | IRAK4 (0.33) | PTGDR2 | |
| SCHEMBL6215155 | 0.84 | PTGDR2 (0.32) | PTGDR2 | |
| SCHEMBL6211888 | 0.84 | PTGDR2 (0.32) | PTGDR2 | |
| SCHEMBL6216101 | 0.84 | PTGDR2 (0.30) | PTGDR2 | |
| SCHEMBL6212704 | 0.84 | PTGDR2 (0.30) | PTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1307203-A4 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2005-08-17 | — | — | EP | claimed |
| EP-1307203-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2003-05-07 | — | — | EP | claimed |
| WO-2001070232-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-09-27 | — | — | WO | claimed |
| EP-1320370-A4 | METHOD OF TREATMENT | SMITHKLINE BEECHAM CORP (US) | 2008-10-22 | — | — | EP | disclosed |
| EP-1307203-A4 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2005-08-17 | — | — | EP | disclosed |
| EP-1320370-A1 | METHOD OF TREATMENT | SmithKline Beecham Corporation (US) | 2003-06-25 | — | — | EP | disclosed |
| WO-2003045909-A2 | METHODS AND INTERMEDIATES FOR THE SYNTHESIS OF AZEPINES | SMITHKLINE BEECHAM CORPORATION (US) | 2003-06-05 | — | — | WO | disclosed |
| EP-1307203-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2003-05-07 | — | — | EP | disclosed |
| WO-2002017924-A1 | METHOD OF TREATMENT | SMITHKLINE BEECHAM CORPORATION (GB) | 2002-03-07 | — | — | WO | disclosed |
| WO-2001070232-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-09-27 | — | — | WO | disclosed |